Quarterly ResultAug 13, 2026, 05:26 PM
Tenon Medical Q2 Revenue +106%, Net Loss Widens; Reverse Split
AI Summary
Tenon Medical reported a significant increase in revenue, up 106% to $2.66 million for the six months ended June 30, 2026, but its net loss widened to $(7.53) million. The company issued a going concern warning, indicating insufficient funds for the next 12 months. To address Nasdaq compliance, Tenon Medical completed a 1-for-35 reverse stock split in August 2026 and regained compliance with the minimum stockholders' equity rule after a July 2026 public offering.
Key Highlights
- Revenue for the six months ended June 30, 2026, increased 106% to $2.66 million from $1.29 million.
- Net loss for the six months ended June 30, 2026, widened to $(7.53) million from $(6.39) million.
- Net loss per share improved to $(23.16) for the six months ended June 30, 2026, from $(39.91).
- Cash and cash equivalents decreased to $1.68 million as of June 30, 2026, from $3.76 million at year-end 2025.
- Total stockholders' deficit was $(1.74) million as of June 30, 2026, down from $5.04 million equity.
- Company issued a going concern warning, stating existing funds are insufficient for the next 12 months.
- Effected a 1-for-35 reverse stock split on August 10, 2026, to regain Nasdaq minimum bid price compliance.
- Regained Nasdaq compliance for minimum stockholders' equity following a July 2026 public offering.
Price Impact
More from TNON